PDE Inhibitors in DMD Study (Acute Dosing Study)
NCT01580501
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
Tadalafil and Sildenafil
Sponsor
Cedars-Sinai Medical Center